Literature DB >> 9651459

Kawasaki disease in the older child.

T Momenah1, S Sanatani, J Potts, G G Sandor, D G Human, M W Patterson.   

Abstract

OBJECTIVES: To determine the prevalence of Kawasaki disease in older children and to evaluate its clinical presentation, time to diagnosis, and outcome in comparison with younger patients with the disease.
METHODOLOGY: A retrospective analysis of all patients discharged with a diagnosis of Kawasaki disease at a pediatric tertiary care hospital over a 12-year period.
RESULTS: A total of 133 patients were included in this study; 7.5% were 9 years of age or older at the time of illness. Patients were grouped by age: infants included children age 1 to 8 years of age and children 9 years of age or older. Older children had a higher frequency of abnormal cardiovascular physical examination (50%) versus children (6%) and infants (10%). The older age group and the infants had a higher prevalence of coronary artery abnormalities and poor left ventricular function than did the 1- to 8-year-olds. Eighty percent of the older children had coronary arteries that were either dilated or aneurysmal, and 30% demonstrated left ventricular dysfunction on initial echocardiography. The number of days to diagnosis after meeting the diagnostic criteria was 5.8 +/- 2.3 for infants, 5.2 +/- 1.5 for older children, and 1.9 +/- 0.3 for children. Older children had a complicated course of Kawasaki disease compared with younger patients.
CONCLUSION: We found a higher prevalence of older children with Kawasaki disease at our center than has previously been reported. Older patients, as well as infants, had a higher rate of coronary artery abnormalities than did the children between 1 and 8 years of age. Older age at the time of illness or a delay in treatment may be important factors in determining cardiac involvement in Kawasaki disease.

Entities:  

Mesh:

Year:  1998        PMID: 9651459     DOI: 10.1542/peds.102.1.e7

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

1.  Infliximab treatment for pediatric refractory Kawasaki disease.

Authors:  Laura L Blaisdell; Jennifer A Hayman; Adrian M Moran
Journal:  Pediatr Cardiol       Date:  2011-07-20       Impact factor: 1.655

Review 2.  Kawasaki disease.

Authors:  Dong Soo Kim
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

3.  Kawasaki disease at British Columbia's Children's Hospital.

Authors:  Regan L Ebbeson; Mark R Riley; Jim E Potts; Derek G Human; Peter N Malleson
Journal:  Paediatr Child Health       Date:  2004-09       Impact factor: 2.253

4.  Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease.

Authors:  Elizabeth S Yellen; Kimberlee Gauvreau; Masato Takahashi; Jane C Burns; Stanford Shulman; Annette L Baker; Nancy Innocentini; Chiara Zambetti; Joan M Pancheri; Adam Ostrow; Jeffrey R Frazer; Robert P Sundel; David R Fulton; Jane W Newburger
Journal:  Pediatrics       Date:  2010-01-25       Impact factor: 7.124

5.  Characteristics and trends in diagnosis of Kawasaki disease outside the usual age range.

Authors:  Qu-Ming Zhao; Min Huang; Mei-Rong Huang; Sun Chen; Fang Liu; Guo-Ying Huang
Journal:  Clin Rheumatol       Date:  2020-08-26       Impact factor: 2.980

6.  Kawasaki disease in Mongolia: results from 2 nationwide retrospective surveys, 1996-2008.

Authors:  Dambadarjaa Davaalkham; Yosikazu Nakamura; Davaakhuu Baigalmaa; Gombojav Davaa; Ochir Chimedsuren; Nyamjav Sumberzul; Tserenkhuu Lkhagvasuren; Ritei Uehara; Hiroshi Yanagawa; Tomisaku Kawasaki
Journal:  J Epidemiol       Date:  2011-06-18       Impact factor: 3.211

7.  Atypical Kawasaki Disease Complicated With Coronary Artery Aneurysm: A Case Report and Review of Literature.

Authors:  Sanjay K Tanti; Sudhir Mishra
Journal:  Cureus       Date:  2021-02-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.